on LDL receptor promoter activity. It is well known that 25HC potently inhibits SREBP activation at submicromolar concentration. As the LDL receptor is transcriptionally regulated by SREBP, 25HC should downregulate LDL receptor promoter activity, as can be seen in this figure. On the
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other hand, mo56HC showed no downregulational activity at the concentration used for filipin staining in Figure 5 . This indicates that the observed alleviation of cholesterol accumulation cannot be attributed to inhibition of the SREBP pathway, further supporting the conclusion that the alleviation was mediated by a pharmacological chaperone effect. 
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Supplemental Experimental Procedures
Membrane preparation. Cells expressing the indicated construct were scraped into PBS and pelleted by centrifugation at 250 g for 5 min at 4 ºC. The pellet was resuspended in TSE buffer (20 mM Tris, pH 7.5, 250 mM sucrose, 1 mM EDTA) and disrupted with a probe sonicator at 0 ºC.
Cell debris was removed by centrifugation at 2,000 g for 5 min. The supernatant was centrifuged at 125,000 g for 1 h to pellet the membranes. The pellets were suspended in TBS and total protein concentrations were measured by BCA assay. The suspensions were diluted to 2.0 µg/µl with TBS.
Full experimental procedure for photoaffinity labeling. Membrane fractions were incubated with 0.5 µM photoaffinity probe mo56AZK in the presence or absence of a competitor for 30 min on ice. Then the membrane fractions were irradiated with 365 nm UV light (from UVP, a UVGL-25 lamp) for 20 min on ice. The samples were lysed by adding one-tenth volume of a solution of 10% SDS and 10% Triton X-100. After 30 min on ice, the samples were collected and click reaction with biotin-azide was conducted using a Click-iT labeling kit (Invitrogen). To the lysed samples, biotin-azide (final concentration 50 µM), Click-iT reaction additive, and CuSO 4 (4 mM) were sequentially added, followed by incubation at 25 ºC for 30 min. Then the samples were diluted with TNET buffer supplemented with 1 mM PMSF and immunoprecipitated with anti-FLAG M2 magnetic beads (4 ºC, overnight). The precipitated proteins were separated on 7.5% SDS-PAGE and transferred to PVDF membrane. The membrane was blocked with 1% BSA in TBST and probed with streptavidin-HRP (Pierce, 1:2000 dilution) to detect biotin label, or anti-FLAG M2 antibody (Sigma, 1:2000 dilution) and HRP-conjugated anti-mouse IgG (Millipore, 1:2000 dilution) to detect FLAG epitope. The HRP activity was visualized using a chemiluminescent substrate (Immobilon Western from Millipore and ECL plus from Amersham).
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Reporter gene assay for LDL receptor promoter. The promoter region (from nucleotide -569 to +56 relative to the transcription start site) of the human LDL receptor gene (GenBank L29401) was amplified from genomic DNA isolated from HEK293 cells, and subcloned into pGL4 vector (Promega) at the KpnI and HindIII site (Grand-Perret et al., 2001 ). HEK293 cells were plated at the density of 25,000 cells/well in a 96-well plate 20-24 h before transfection. LDLr-luc (50 ng/well) and CMX-β-Gal (50 ng/well) plasmids were cotransfected using polyethyleneimine max (500 ng/well, Polysciences, Inc.). At 4 h after transfection, prediluted test compounds were added in RPMI1640 and incubated for 20-22 h. Measurements of luciferase activity were conducted as described by Baker et al. (2003) with slight modifications. Briefly, cells were lysed with 50 µl of buffer (30 mM Tricine, 8 mM Mg(OAc) 2 , 0.2 mM EDTA) containing 100 mM 3-mercapto-1,2-propanediol, 1% Triton X-100, 65 mM ATP, 0.5 mM CoA, and 40 µM D-luciferin, and the luminescence signal was measured after 1 min at room temperature on a Wallac 1420 multilabel counter (PerkinElmer Life Sciences). For correction of transfection efficiency, β-Gal activity (as absorbance at 405 nm) was measured after incubation with 125 µL of buffer (60 mM Na 2 HPO 4 and 40 mM NaH 2 PO 4 ) containing 1 mg/ml o-nitrophenyl-β-D-galactopyranoside and 100 mM 3-mercapto-1,2-propanediol for 5-30 min at ambient temperature.
DiI(1,1'-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate)-LDL Uptake assay.
DiI-LDL was purchased from Biomedical technologies. At day 1, HEK293 cells were plated on poly-D-lysine coated glass-bottom dish. At day 2, cells were treated with the indicated compounds prediluted with DMEM (5% FBS). After 24 h of incubation, DiI-LDL (final 10 µg/mL) were added to the cells and incubated for additional 5 h, then cells were washed with PBS and fixed. Fifteen images per condition were acquired, and fluorecence intensity was measured.
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General methods for organic synthesis. NMR spectra ( 1 H and 13 C) were recorded on JEOL JNMGX500 (500 MHz) spectrometer. Chemical shifts (δ) are reported in ppm downfield from the internal standard tetramethylsilane (δ: 0.00). Fast atom bombardment mass spectra (FAB-MS) and high resolution mass spectra (HR-MS) were measured on JEOL JMA-HX110 mass spectrometer. Flash column chromatography was performed using silica gel 60 (particle size 0.060-0.210 mm) purchased from Kanto Chemical. All other reagents and solvents were purchased from Aldrich, Tokyo Chemical Industry, Wako Pure Chemical Industries, and Kanto
Chemical, and of reagent grade. To dry organic extracts, we used magnesium sulfate unless otherwise specified.
Synthesis of mo25HC.
2-Bromo-1-morpholinoethanone (1). To a vigorously stirred mixture of morpholine (265 mg, 3.04 mmol) in chloroform (7 mL) and aqueous sodium bicarbonate (7 mL) at 0 ºC was added bromoacetyl chloride (252 µL, 3.10 mmol). Stirring was continued overnight at ambient temperature. The biphasic mixture was separated and the organic phase was washed (dilute aqueous HCl and brine), dried, and concentrated to afford the title compound (360 mg, 1.76 mmol, yield 58%) as a clear oil. 140.25, 122.07, 79.74, 71.06, 67.97, 66.84, 66.78, 56.70, 56.06, 50.09, 45.84, 44.40, 42.31, 42.17, 39.73, 38.84, 37.04, 36.76, 36.43, 35.71, 31.88, 31.84, 29.32, 29.17, 28.21, 28.17, 24.24, 21.03, 20.75, 19.33, 18.66, 11.84 168.45, 140.26, 122.10, 79.76, 68.01, 66.85, 66.82, 56.72, 56.13, 50.12, 45.86, 42.30, 42.18, 39.74, 39.50, 38.85, 37.05, 36.78, 36.17, 35.76, 31.90, 31.85, 28.20, 28.19, 28.00, 24.26, 23.81, 22.80, 22.54, 21.05, 19.34, 18.70, 11.84 168.45, 140.25, 138.30, 129.27, 122.10, 79.75, 67.99, 66.85, 66.81, 56.82, 55.93, 51.22, 50.13, 45.85, 42.20, 42.18, 40.48, 39.63, 38.85, 37.05, 36.79, 31.89, 31.87, 31.85, 28.90, 28.19, 25.40, 24.34, 21.20, 21.08, 21.03, 19.35, 18.97, 12.24, 12.03 168.66, 138.26, 129.35, 76.10, 76.06, 75.84, 68.07, 66.82 (2C), 56.01 (2C), 51.23, 45.84 (2C), 42.63, 42.21, 40.51, 39.82, 38.49, 37.45, 34.57, 32.18, 31.87, 30.18, 28.89, 27.33, 25.39, 24.20, 21.19, 21.13, 21.07, 18.99, 16.79, 12.34, 12.23 .
Compound 5. A solution of 4 (1308.8 mg, 2.281 mmol) in CH 2 Cl 2 (35 mL) and MeOH (35 mL) was cooled to -78 ºC and treated with O 3 for 1 h. Then NaBH 4 (142.6 mg, 3.769 mmol) was added to it at -78 ºC. The mixture was stirred at ambient temperature overnight, then poured into water and the whole was extracted with CH 2 Cl 2 . The organic layer was washed with brine, dried (Na 2 SO 4 ), filtered and evaporated. Open column chromatography (hexane / EtOAc / MeOH = 10 / S16 10 / 1 to 0 / 10 / 1) gave compound 5 (654.4 mg, 1.326 mmol, 58% yield) as a white solid. 76.06, 76.01, 75.68, 67.87, 66.76 (2C), 55.73, 54.33, 46.04, 45.88, 45.53, 43.04, 42.26, 39.81, 38.41, 37.37, 36.76, 34.47, 32.18, 30.22, 28.04, 27.39, 24.23, 21.09, 17.52, 16.71, ).
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Supplemental Scheme 4. Synthesis of mo56AZK.
Methyl 3-hydroxymethyl-5-nitrobenzoate (9).
A solution of 5-nitroisophthalic acid monomethyl ester (556 mg, 2.47 mmol) in dehydrated THF (10 mL) was treated with borane THF complex (1.03 M in THF, 2.5 mL, 2.58 mmol) at 0 ºC, and then stirred overnight at ambient temperature.
To the reaction mixture was added aqueous potassium carbonate. After extraction with EtOAc, the organic layer was washed (water, brine), dried, and concentrated to afford the compound 9 was treated with oxalyl chloride (0.018 mL) and a catalytic amount of DMF at 0ºC. The reaction mixture was stirred for 30 min at ambient temperature, and added to a mixture of 8 (54 mg, 0.110 mmol) in CH 2 Cl 2 (3 mL) and 0.5 M aqueous sodium bicarbonate (4 mL) at 0 ºC. The whole was allowed to warm to ambient temperature, and then stirred overnight, diluted with EtOAc, and washed with water and brine. The organic phase was dried, concentrated, and subjected to flash column chromatography (EtOAc / CH 2 Cl 2 / MeOH = 10 / 10 / 1) to give mo56AZK (45.6 mg, 0.069 mmol, 63%) as an off-white powder. 168. 85, 165.81, 140.57, 136.40, 126.04, 124.27, 123.58, 117.97, 81.27, 78.63, 75.86, 75.11, 74.88, 66.79, 66.22, 66.13, 55.24, 53.73, 45.28, 45.20, 44.86, 42.47, 41.71, 39.33, 37.82, 36.55, 36.22, 33.69, 31.63, 29.78, 27.47, 26.88, 23.70, 20.58, 16.90, 16.02, 11.63 
